福元医药：利丙双卡因乳膏获药品注册证书

Core Viewpoint - Fuyuan Pharmaceutical (601089) has received the drug registration certificate for Lidocaine and Prilocaine Cream from the National Medical Products Administration, indicating a significant milestone in its product development and market entry [1] Company Summary - Fuyuan Pharmaceutical's wholly-owned subsidiary, Fuyuan Pharmaceutical Co., Ltd., has been granted the drug registration certificate for Lidocaine and Prilocaine Cream, which is intended for local anesthesia of the skin [1] - The drug registration standard number is YBH15772025, with a specification of 5g containing 125mg of Lidocaine and 125mg of Prilocaine [1] - The total R&D investment for this drug by Fuyuan Pharmaceutical Co., Ltd. has reached RMB 5.3826 million [1] Industry Summary - According to data from Minet, the estimated sales revenue for Lidocaine and Prilocaine Cream in China's three major terminal markets is approximately RMB 615 million in 2024 [1]